NA
GRCL

NewEdge Advisors’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

NewEdge Advisors’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-227
Closed -$865 – 3700
2023
Q2 		$865 Buy
+227
New +$865 ﹤0.01% 3266